Crizotinib: aseptic abscesses in multiple organs during treatment of EML4-ALK-positive NSCLC
Authors:
Open Access
- 9 August 2021
- journal article
- letter
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 147 (12) , 3769-3771
Abstract
Purpose: We report a novel side effect of Crizotinib, an oral ALK inhibitor used in the treatment of non-small cell lung cancer (NSCLC) with activating rearrangement of EML4-ALK. It expands the known spectrum of complications of Crizotinib. Methods: Clinical case report. Results: Multiple aseptic and recurrent abscesses were observed in the liver, thoracic wall as well as in both kidneys in a 75-year-old female patient suffering from NSCLC who had been treated with Crizotinib for almost 2 years. After discontinuation of the treatment the abscesses dissolved spontaneously and did not reoccur. Conclusion: Aseptic abscesses under treatment with Crizotinib are not restricted to the kidneys as described before, but can also occur in other abdominal organs as the liver and even in the thoracic wall. We postulate that this finding may point to a yet unknown not tissue-dependent mechanism of action.Keywords
Funding Information
- Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
This publication has 6 references indexed in Scilit:
- Renal Injury during Long-Term Crizotinib TherapyInternational Journal of Molecular Sciences, 2018
- Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1Oncotarget, 2016
- Crizotinib versus Chemotherapy in AdvancedALK-Positive Lung CancerNew England Journal of Medicine, 2013
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cellsAmerican Journal of Physiology-Cell Physiology, 2010
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007